|
Re: Epigenetics market to reach $16.3 Billion in 6 years (article)
|
8
|
Resverlogix Corp.
|
Jan 18, 2016 01:35PM
|
|
Re: Finance
|
8
|
Resverlogix Corp.
|
Aug 09, 2020 08:23PM
|
|
3600 patient years
|
8
|
Resverlogix Corp.
|
Feb 16, 2018 03:27PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
8
|
Resverlogix Corp.
|
Sep 06, 2019 10:19PM
|
|
German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
8
|
Zenith Epigenetics
|
Jun 03, 2021 10:45AM
|
|
Compounds and Autoimmune
|
8
|
Zenith Epigenetics
|
Jun 21, 2016 12:10PM
|
|
Age, MoCA and CKD
|
8
|
Resverlogix Corp.
|
Nov 18, 2019 05:52PM
|
|
Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
8
|
Resverlogix Corp.
|
Mar 31, 2020 08:11AM
|
|
Re: Our own BKC on the webcast
|
8
|
Resverlogix Corp.
|
Feb 04, 2021 12:53PM
|
|
April 29, 2021: Triple Negative Breast Cancer Drug Development Digital Summit 2021
|
8
|
Zenith Epigenetics
|
Apr 28, 2021 11:43AM
|
|
Re: Q4 2019 Events
|
8
|
Resverlogix Corp.
|
Nov 01, 2019 11:35AM
|
|
Re: Prof Kausik Ray's latest tweet
|
8
|
Resverlogix Corp.
|
Nov 16, 2019 07:04AM
|
|
Epigenetics: A closer look at Apabetalone
|
8
|
Resverlogix Corp.
|
Sep 02, 2016 01:30PM
|
|
Re: Holding the company's feet to the fire....
|
8
|
Resverlogix Corp.
|
Jan 31, 2019 09:11PM
|
|
Re: Gran Oso....
|
8
|
Resverlogix Corp.
|
Dec 20, 2019 06:41AM
|
|
Re: RVX continuous good news
|
8
|
Resverlogix Corp.
|
Jun 01, 2015 10:55PM
|
|
Re: Reata, Friedreich’s Ataxia and Kidney Disease
|
8
|
Resverlogix Corp.
|
Oct 17, 2019 09:50PM
|
|
Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
8
|
Resverlogix Corp.
|
May 02, 2019 11:45PM
|
|
Re: It will be surprising to me....
|
8
|
Resverlogix Corp.
|
Aug 08, 2018 09:48AM
|
|
Re: Timelines for notice of meeting for AGMs
|
8
|
Resverlogix Corp.
|
Sep 14, 2016 02:28PM
|
